{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:18Z","timestamp":1786991238149,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jad.2012.01.047","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T06:48:09Z","timestamp":1330325289000},"page":"247-258","source":"Crossref","is-referenced-by-count":69,"title":["A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode"],"prefix":"10.1016","volume":"138","author":[{"given":"Joris","family":"Berwaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Melkote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Nuamah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.01.047_bb0005","author":"APA"},{"key":"10.1016\/j.jad.2012.01.047_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the Scale for Suicide Ideation","volume":"47","author":"Beck","year":"1979","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.jad.2012.01.047_bb0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","article-title":"Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study","volume":"129","author":"Berwaerts","year":"2010","journal-title":"Journal of Affective Disorders"},{"issue":"1\u20132","key":"10.1016\/j.jad.2012.01.047_bb0025","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jad.2010.06.030","article-title":"Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose\u2013response study","volume":"136","author":"Berwaerts","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.01.047_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2007.03.003","article-title":"Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study","volume":"93","author":"Davidson","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jad.2012.01.047_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"Journal of the American Statistical Association"},{"key":"10.1016\/j.jad.2012.01.047_bb0040","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Annals Statistics"},{"key":"10.1016\/j.jad.2012.01.047_bb0045","series-title":"AIMS. Abnormal Involuntary Movement Scale. ECDEU Assessment for Psychopharmacology. Rev. Ed","year":"1976"},{"key":"10.1016\/j.jad.2012.01.047_bb0050","series-title":"Group Sequential Methods with Applications to Clinical Trials","author":"Jennison","year":"2000"},{"key":"10.1016\/j.jad.2012.01.047_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2006.09.012","article-title":"Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial","volume":"90","author":"Kane","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jad.2012.01.047_bb0060","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/biomet\/74.1.149","article-title":"Design and analysis of group sequential tests based on the type I error spending rate function","volume":"74","author":"Kim","year":"1987","journal-title":"Biometrika"},{"key":"10.1016\/j.jad.2012.01.047_bb0070","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2307\/2336502","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.jad.2012.01.047_bb0075","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.biopsych.2007.01.017","article-title":"Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study","volume":"62","author":"Marder","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0080","doi-asserted-by":"crossref","first-page":"S595","DOI":"10.1016\/S0924-9338(09)70828-4","article-title":"Quetiapine or lithium versus placebo for maintenance treatment of bipolar I disorder after stabilization on quetiapine","volume":"24","author":"Nolen","year":"2009","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0090","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00213-010-2056-8","article-title":"Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder","volume":"213","author":"Popovic","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2012.01.047_bb0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","article-title":"Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder","volume":"68","author":"Quiroz","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0100","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","article-title":"A note on competing risks in survival data analysis","volume":"91","author":"Satagopan","year":"2004","journal-title":"British Journal of Cancer"},{"issue":"Suppl. 20","key":"10.1016\/j.jad.2012.01.047_bb0105","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"key":"10.1016\/j.jad.2012.01.047_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jad.2012.01.047_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.01.047_bb0125","doi-asserted-by":"crossref","first-page":"e1000434","DOI":"10.1371\/journal.pmed.1000434","article-title":"Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature","volume":"8","author":"Tsai","year":"2011","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jad.2012.01.047_bb0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder","volume":"12","author":"Vieta","year":"2010","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2012.01.047_bb0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"The British Journal of Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T14:30:15Z","timestamp":1543156215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0165032712000948"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.01.047","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}